A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis
Clinical trial NCT06878404 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06878404
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-21
- Primary completion
- 2026-05-25
- Enrollment
- 552
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.